Frequently Asked Questions
The North America Prescription Digital Therapeutics (PDTx) Market is projected to grow at a CAGR of 22.0% during the forecast period by 2030.
The future market value of the North America Prescription Digital Therapeutics (PDTx) Market is expected to reach USD 3688.53 million by 2030.
The major players in the North America Prescription Digital Therapeutics (PDTx) Market are ResMed (U.S.), SAMSUNGHEALTHCARE (South Korea), Biofourmis (U.S.), Novartis AG (Switzerland), Medtronic (Ireland), Pear Therapeutics, Inc. (U.S.), Voluntis (France), Omada Health, Inc. (U.S.), etc.
The countries covered in the North America Prescription Digital Therapeutics (PDTx) Market are U.S., Canada and Mexico in North America.